Agnieszka Pałucha-Poniewiera
Pałucha-Poniewiera, Agnieszka
VIAF ID: 566144782720309921249 (Personal)
Permalink: http://viaf.org/viaf/566144782720309921249
Preferred Forms
- 100 0 _ ‡a Agnieszka Pałucha-Poniewiera
-
4xx's: Alternate Name Forms (6)
Works
Title | Sources |
---|---|
Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc. | |
The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent | |
Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats. | |
Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu₄ receptor | |
Are compounds acting at metabotropic glutamate receptors the answer to treating depression? | |
Chronic imipramine treatment reduces inhibitory properties of group II mGlu receptors without affecting their density or affinity. | |
Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex | |
Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain hippocampus. | |
Glutamate-Based Drug Discovery for Novel Antidepressants | |
Glutamatergiczne receptory metabotropowe (mGluR) : nowe oblicze glutaminianu - nowe perspektywy terapii | |
The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems. | |
In the amygdala anxiolytic action of mGlu5 receptors antagonist MPEP involves neuropeptide Y but not GABAA signaling | |
The influence of the duration of chronic unpredictable mild stress on the behavioural responses of C57BL/6J mice | |
Interaction of zinc with antidepressants in the forced swimming test in mice | |
Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping | |
Investigational NMDA receptor modulators for depression | |
Involvement of CRF but not NPY in the anxiety regulation via NMDA receptors | |
The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test | |
Is the mGlu5 receptor a possible target for new antidepressant drugs? | |
Negative Allosteric Modulators of mGlu Receptor as Putative Antipsychotic Drugs | |
NMDA antagonists under investigation for the treatment of major depressive disorder | |
A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action | |
On the mechanism of anti-hyperthermic effects of LY379268 and LY487379, group II mGlu receptors activators, in the stress-induced hyperthermia in singly housed mice | |
Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents | |
The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice | |
Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist | |
Prolonged administration of antidepressant drugs leads to increased binding of [(3)H]MPEP to mGlu5 receptors. | |
The role of glutamatergic modulation in the mechanism of action of ketamine, a prototype rapid-acting antidepressant drug | |
Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms. |